ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

Local University Competing for Part FCRF Contract

December 4, 1981

In Brief: OMB tells NCI Mislead Congress, Refuses Higher Budget; Ford Says He Support Program

March 28, 1975

Virus Program Report On Scientific Activities

August 8, 1975

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

In Brief: Wieand Named Director, Biostatistical Center For NSABP; LeMaistre Honored By AMA

June 30, 1995